NEW YORK (PRWEB)
November 02, 2021

Tannenbaum Helpern is a sponsor at this year’s Cannabis World Congress & Business Expo (CWCBExpo), a business-to-business trade show for the legalized cannabis industry and a leading forum for cannabis dispensary owners, growers, suppliers, investors, medical professionals, regulators, legal counsel and entrepreneurs.

In their November 5th session entitled, MRTA She Wrote: Understanding NY’s Cannabis Laws to Take Your Business to Primetime, co-chairs of Tannenbaum Helpern’s Cannabis Industry practice James Rieger and Paul Sarkozi will discuss strategies for approaching the NY cannabis market in light of the evolving statutory and regulatory environment – most significantly, New York’s recently enacted Marijuana Regulation and Taxation Act. Among the issues they will highlight are the early guidance provided by New York’s Cannabis Control Board, the types of licenses available to businesses and the steps that business should start taking right now to position themselves for success in the anticipated $4 billion New York commercial cannabis market.

CWCBExpo will be in New York at the Javits Convention Center from November 4th to November 6th. Be sure to check out our booth #200 while at the expo.

About Tannenbaum Helpern’s Cannabis Industry practice

An early legal service provider in the cannabis space, Tannenbaum Helpern’s Cannabis Industry practice has more than four years of experience advising some of the biggest cannabis investors in the industry. Tannenbaum Helpern attorneys are actively staying on top of cannabis developments through their involvement with cannabis associations and as members of the New York State Bar Association’s Committee on Cannabis Law. Our lawyers are frequent speakers on cannabis related topics at industry events and serve as thought leaders in articles published through a wide variety of media outlets and professional organizations.

About Tannenbaum Helpern Syracuse & Hirschtritt LLP

Since 1978, Tannenbaum Helpern Syracuse & Hirschtritt LLP has combined a powerful mix of insight, creativity, industry knowledge, senior talent and transaction expertise to successfully guide clients through periods of challenge and opportunity. Our mission is to deliver the highest quality legal services in a practical and efficient manner, bringing to bear the judgment, common sense and expertise of well trained, business minded lawyers. Through our commitment to service and successful results, Tannenbaum Helpern continues to earn the loyalty of our clients and a reputation for excellence. For more information, visit http://www.thsh.com or follow us on Twitter: @THSHLAW.

Share article on social media or email:

WCG FDAnews

FALLS CHURCH, Va. (PRWEB)
November 01, 2021

16th Annual FDA Inspections vSummit

An FDAnews Virtual Summit

Tuesday-Wednesday, Nov. 16-17, 2021

https://wcg.swoogo.com/fda-inspections-summit

Clinical trials were upended by the COVID-19 pandemic and the FDA was forced to adjust most of their inspection procedures. Will inspections ever go back to the way they were? Will the agency rely more heavily on remote tools going forward? Has your team adapted to the technologies that arose out of the health crisis?

To succeed in clinical trials, one needs to be able to navigate these complicated questions — and one needs to do it effectively and efficiently. Luckily, this year’s 16th Annual FDA Inspections vSummit can help.

The summit’s dedicated clinical trial track includes practical advice from current and former FDA officials, along with other seasoned industry leaders. These tips will bring attendees a deeper understanding of the state of the agency and provide a framework for moving forward. In these virtual, interactive and expert-led sessions, dig deeply into the most relevant and timely inspections conversations in clinical trials.

Here’s some of what one will experience:

• 
  At the start of this program, one will explore the FDA’s expectations for future inspections with Elizabeth Miller, Pharm.D., Assistant Commissioner Medical Products & Tobacco Operation Office of Regulatory Affairs, FDA.
• Follow that conversation with discussions about the ways COVID-19 encouraged a more streamlined approach to trial management, current agency policies around remote informed consent and how to best assess risk in recall situations.
• On the second day, get straightforward details on how to manage an inspection — and what to avoid — from Steve Niedelman, former FDA Deputy Associate Commissioner for Regulatory Operations.
• Attendees will then consider what inspections will look like in a post-COVID world, how to adequately vet and work with vendors and the significant benefits of artificial intelligence.

There have been tremendous changes to the FDA’s inspections process since the start of the COVID-19 pandemic and there are only more to come. Learn the lessons needed to navigate the ever-changing world of inspections, whether that means a return to on-site inspections or a continued integration of remote processes.

Virtual Workshop Details:

16th Annual FDA Inspections vSummit

An FDAnews Virtual Summit

Tuesday-Wednesday, Nov. 16-17, 2021

https://wcg.swoogo.com/fda-inspections-summit

Tuition:

Single Attendee – $597.00

Group of 2-4 Attendees (Save 10%) – $527.00

Group of 5-6 Attendees (Save 15%) – $492.00

Group of 7-9 Attendees (Save 20%) – $458.00

Group of 10+ Attendees (Save 25%) – $423.00

Easy Ways to Register:

Online: https://wcg.swoogo.com/fda-inspections-summit

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

“Dr. Green dedicated his career to furthering our understanding of skin regeneration and improving the outcomes for patients,” Dr. Morgan said. “I am honored not only to build on his work in helping improve the lives of patients, but to do so together with Shriners Hospitals for Children.”

BOSTON (PRWEB)
November 01, 2021

Shriners Children’s is pleased to announce that a cutting-edge gene and stem cell therapy research program to cure the rare skin blistering disorder is to be supported by the Howard Green Center for Children’s Skin Health & Research at Shriners Hospitals for Children — Boston.

The lead scientist is Dr. Jeffrey Morgan who has proven track record of successful innovation and leadership skills. Dr. Morgan will guide this program as it pursues its goal of improving the outcomes and lives of patients with burns, skin disorders and dermatological conditions. The expert co-investigators on the research project are Robert Sheridan M.D., Mehmet Toner Ph.D., and Martin Yarmush M.D., Ph.D., all at Massachusetts General Hospital (MGH), Harvard Medical School (HMS) and Shriners Children’s Boston.

Dr. Morgan has extensive experience in genetically engineering skin to treat various genetic disorders or to deliver local wound healing factors. His interdisciplinary research has produced 110 publications in high-impact, peer-reviewed scientific journals. Working in translation and commercialization of technologies, Dr. Morgan is an inventor on thirteen issued patents and was elected a Fellow of the National Academy of Inventors. Innovations developed in his laboratories are distributed worldwide. Dr. Morgan has served in a number of leadership positions in academia as well as start-up companies.

Dr. Morgan trained at Massachusetts Institute of technology with Howard Green, M.D. Dr. Green was the first to grow skin grafts using a patient’s own cells, one of the earliest examples of stem cell therapy. The first grafts from cultured skin were used to treat two patients with life threatening burns at Shriners Hospitals for Children — Boston in the early 1980s, cementing the impact of Dr. Green’s discovery as well as his bond with Shriners Hospitals for Children.

“Dr. Green dedicated his career to furthering our understanding of skin regeneration and improving the outcomes for patients,” Dr. Morgan said. “I am honored not only to build on his work in helping improve the lives of patients, but to do so together with Shriners Hospitals for Children.”

“Dr. Morgan’s appointment as principal investigator will help the Howard Green Center for Children’s Skin Health & Research take the next step in caring for patients with devastating skin injuries and conditions,” said Jerry G. Gantt, Chairman of the Board of Trustees of Shriners Hospitals for Children. “Dr. Morgan’s leadership in the field and longtime connection with Dr. Howard Green make him a natural choice to lead the research project, and we are honored to have him as an important part of our Shriners Children’s family.”

About the Howard Green Center for Children’s Skin Health & Research at Shriners Children’s Boston

Founded in 2016, the Howard Green Center for Children’s Skin Health and Research at Shriners Hospitals for Children — Boston is a first-of-its kind center dedicated to advancing the field of regenerative medicine. The mission is to engage in translational research projects that work hand-in-hand with clinical practice to move regenerative medicine along the discovery continuum to bring new treatments to children more quickly. The ultimate goal is to further improve the outcomes and lives of patients with burns, skin disorders and dermatological conditions by providing world-class care regardless of the families’ ability to pay.

The Center is the vision of Dr. Green and his family. By making a generous and transformational gift to Shriners Hospitals for Children — Boston, Mrs. Rosine Kauffmann Green ensured her late husband’s work would continue on and help children in Boston and around the world.

About Shriners Children’s

Shriners Children’s is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our health care system provides care for children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care and services are provided regardless of the families’ ability to pay. Since opening its first location in 1922, the health care system has treated more than 1.5 million children. To learn more, please visit shrinershospitalsforchildren.org.

Media Contact:

Mel Bower, Shriners Hospitals for Children

813-281-8643, mbower@shrinenet.org

Share article on social media or email:

“This strategic relationship is a major milestone for us, and at VFS we are very pleased to have found a partner which shares our passion” Jon Stevens, Chief Financial Officer of Verde Financial Solutions.

PHILADELPHIA (PRWEB)
November 01, 2021

Verde Financial Solutions (VFS), the global leader in Unattended Retail Manufacturing has announced an exclusive strategic sales partnership with Naturepay. The strategic partnership focuses on bringing mainstream PIN Based Debit processing solutions to Cannabis, CBD and Hemp related businesses across the country via Unattended Retail Kiosks. Naturepay has emerged as a leading reseller of payment solutions to merchants conducting business within the Cannabis industry, focusing on delivering unparalleled service to merchants and sales partners.

VFS, has the opportunity to deliver an unique customer experience to the end consumer with a much broader audience of Cannabis merchants with its State of the Art Kiosks. This new sales partnership with Naturepay enables Verde to work with a like-minded partner with extensive experience in helping Cannabis-related merchants to obtain steady and reliable PIN Based Debit processing. Verde will continue to focus on providing State of the Art Kiosks to the US Cannabis Industry.

“Naturepay, The brand Cannabis merchants have entrusted for more than 7 years, is excited to be finalizing our exclusive sales agreement with Verde to bring their state of the art self-serve kiosks to the cannabis market. We are excited to partner in Verde’s mission to deliver kiosks to those Cannabis merchants that are most in need. Particularly for retail store-front merchants, where we will be able to offer Verde’s Technology to the masses,” said Justin Cummings, Vice President at Naturepay.

“This strategic relationship is a major milestone for us, and at VFS we are very pleased to have found a partner which shares our passion for delivering everyday Profitability and reliability that the industry thirsts for. It is our visions combined which will allow Cannabis retailers the ability to grow their business with immediate results.” said Jon Stevens, Chief Financial Officer of Verde Financial Solutions.

About Verde:

Verde Financial Solutions Provides Automated Unattended Retail Systems for CBD, THC and everything in between. We are the only Manufacturer and Distributor to have fully integrated Age Verification, Payment Systems and Mobile App to create a seamless consumer buying experience. With our state of the art AI, combined with Live Inventory, Geofencing, and the ability to Switch Marketing Ads in Minutes our Distributors have even more options to increase their Revenue and Sales Capacity. This is why the future of vending has now arrived. Whether it’s Pre Order and Pick up, Checking for Inventory, or Buying at the Machine… We are so much MORE than a Kiosk. For more information on Verde visit http://www.verderetail.com

About Naturepay:

Naturepay has been pioneering the cannabis payments landscape for close to a decade. Naturepay provides compliant and transparent cashless payment solutions to licensed cannabis dispensary and delivery companies around the country. Naturepay’s connections to “cannabis friendly” banking, compliant and transparent cashless payment options, as well as seamless capabilities to integrate with point of sale systems position us for continuous growth in the industry. For more information on NaturePay, visit http://www.naturepay.net

Share article on social media or email:

Home Dialyzors United

“DVAC’s mission is to draw attention to the frontline impacts of the decisions made in Washington and that’s why we are thrilled to welcome Home Dialyzors United in joining our efforts to further spotlight the voices of dialysis patients. — Dr. Miller

WASHINGTON (PRWEB)
November 01, 2021

Today, the Dialysis Vascular Access Coalition (DVAC) announced that Home Dialyzors United (HDU) will be officially joining their efforts to amplify the voices of dialysis patients who depend on vascular access services for life-saving care. DVAC continues to gain momentum and grow as issues related to dialysis vascular access cause concern in Washington.

Nieltje Gedney, the HDU executive director, said “HDU is excited to team up with DVAC to ramp up advocacy efforts to increase the voice of dialysis patients who receive their care at home. As a solo home hemodialyzor for over eight years, I know that nothing is more important to my health and safety than my lifeline—a working fistula. Without that lifeline, I would not be able to successfully dialyze. We are not just numbers on a budget spreadsheet because we live with the impacts of the decisions of federal policy makers every day.”

Gedney continued, “HDU members and all dialysis patients are facing headwinds from federal decision-makers about the future of vascular access centers, which provide specialized and patient-focused care for vascular access creation and preservation services in an office or ASC setting. Look no further than the recently proposed 20% across the board Medicare cut to dialysis vascular access services; cuts that would come on top of the 2017 CMS payment cuts to a key vascular access code by 39%.”

Dr. Gregg Miller, DVAC Health Policy Chair, said “DVAC’s mission is to draw attention to the frontline impacts of the decisions made in Washington and that’s why we are thrilled to welcome Home Dialyzors United in joining our efforts to further spotlight the voices of dialysis patients. We want to make sure all dialysis patients can receive the gold-standard of care from a doctor they trust and that patients aren’t squeezed out of local VACs and face more health inequity as a result.”

###

To learn more about DVAC and its mission, visit http://www.dialysisvascularaccess.org. For more information about HDU, visit homedialyzorsunited.org.

Share article on social media or email:

PetMeds®

“Cats and dogs are considered senior pets at around seven years of age, and for most, that’s when their life is just beginning,” says Larissa Schenck, Director of Marketing at PetMeds® “It’s not uncommon for pets to stay active and healthy for another seven years, or even longer.”

DELRAY BEACH, Fla. (PRWEB)
November 01, 2021

November has most Americans thinking about family, making it a great time to celebrate National Senior Pet Month. Whether pet owners have a beloved senior cat or dog at home or are thinking of adding a grizzled addition to their family, PetMeds® is raising awareness and shining a light on misconceptions with a month-long giveaway.

Most people looking to adopt a pet tend to look for puppies and kittens, while senior pets in shelters get overlooked. Senior pets are often seen as set in their ways and less likely to adapt to their new family. The truth is, older cats and dogs have a lot of love to give, and there are many perks to adopting a senior.

Senior cats and dogs tend to sleep more than their younger counterparts, having long surpassed the wild puppy or kitten stage. Adopters of senior pets can look forward to quiet evenings on the couch with a snoozing dog or purring cat curled up in their lap.

Older pets also have a predictable personality. Shelters and humane societies often document the adoptee’s history with kids, other pets, and different environments to ensure the pet is a good match for the potential adopter.

The biggest concern pet parents may have about adopting a senior is the heartbreaking perception that they will fall in love with the animal, only to have to say goodbye to them after a few months. Fortunately, domestic animals are living longer as we see improvements in nutrition, veterinary medicine, and public knowledge about pet preventative care.

“Cats and dogs are considered senior pets at around seven years of age, and for most, that’s when their life is just beginning,” says Larissa Schenck, Director of Marketing at PetMeds® “It’s not uncommon for pets to stay active and healthy for another seven years, or even longer.”

In celebration of National Senior Pet Month, all cat and dog parents are invited to enter the PetMeds® Senior Pet Month Giveaway for a chance to win a Special Senior Support Package that will include Animal Eye Defense, Vetri-DMG, and Super Pure Omega 3. The Special Senior Support Packages will also include Feliway for cat parents, and Adaptil for dog parents. One lucky grand prize winner will receive a couch cover – for those quiet evenings on the couch with your special snoozing senior.

The PetMeds® Senior Pet Month Giveaway runs from Monday November 1, 2021, through Tuesday, November 30 2021. Everyone who enters from 12:01 AM Eastern Time (“ET”) November 1, 2021 to November 30 2021 at 11:59 PM ET is eligible to win.

About PetMeds®

Founded in 1996, Petmeds.com is America’s Most Trusted Pet Pharmacy® providing fast, easy and helpful service to over ten million customers across the U.S. by delivering prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the PetMeds® mobile app available for free at Google Play for Android and the App Store for iOS.

Share article on social media or email:

NEW HAVEN, Conn. (PRWEB)
November 01, 2021

Biorez Inc., a New Haven, late-stage start-up advancing tendon and ligament healing, today announced the appointment of Jeff Grebner as Director of Clinical Affairs. Grebner joins the Biorez team at an opportune time as the company hits key clinical and procedural milestones with its proprietary BioBrace Implant technology in 2021.

“Jeff is a thoughtful clinical leader with extensive relationships and experience managing end-to-end pre and post-market evidence generation initiatives from concept through completion and publication,” said Kevin Rocco, Founder and CEO of Biorez. “He developed and managed the clinical study plans for three prior successful medical device startups that were acquired in transactions totaling over $1 billion. Jeff was also a key member of the Rotation Medical team, where he orchestrated the generation of post-market clinical data that drove market adoption for their regenerative implant for rotator cuff repair leading to a successful acquisition and transition to Smith & Nephew.”

Grebner brings more than 20 years of clinical affairs experience at both large and small companies. Most recently, he served as Head of Clinical Development with Philips Hospital Patient Monitoring and has held senior clinical management roles with Smith & Nephew / Rotation Medical and Entellus Medical.

“I’m passionate about the potential for the BioBrace technology to improve tendon and ligament healing and have been impressed with initial clinician feedback,” said Grebner. “I look forward to partnering with orthopedic and sports medicine health care professionals to deliver robust evidence to further demonstrate the value of BioBrace.”

About Biorez Inc.:

Biorez is a New Haven-based medical device start-up focused on advancing the healing of soft tissues using its proprietary BioBrace™ Implant technology. The company has pioneered the BioBrace™ Implant, a breakthrough biocomposite scaffold featuring a highly-porous collagen matrix that is reinforced with bioresorbable microfilaments. The BioBrace Implant is intended to reinforce and regenerate soft tissue repairs in several clinical applications. The BioBrace Implant is in the late development stage and has not yet been approved for use by any regulatory agency, including the U.S. Food and Drug Administration. More information is available at http://www.biorez.com.

Share article on social media or email:

Over the past few years, telehealth has rapidly grown in adoption as a safe, affordable, and convenient way for patients to satisfy their healthcare needs without sacrificing efficacy or quality.

FRISCO, Texas (PRWEB)
November 01, 2021

BioDatAi, a subsidiary of Dallas-based Economic Transformation Technologies (ETT), which is an accelerator and integrator of innovative technologies united in the mission of economic transformation and corporate performance, has today announced a strategic agreement with iHub Global to deliver telemedicine and telehealth services to iHub’s more than one million and growing affiliate members and clients globally.

“Over the past few years, telehealth has rapidly grown in adoption as a safe, affordable, and convenient way for patients to satisfy their healthcare needs without sacrificing efficacy or quality,” stated Kelly Cook, CEO of ETT. “Stimulated by the COVID-19 pandemic and its impact on patients access to medical care, utilization of this digital health technology has surged to over 36% across the United States. Telehealth, in itself, supports social distancing efforts by ensuring that care is always available to those in need by triaging and addressing low-risk urgent care needs, along with providing a means to deliver the necessary attention to those with chronic diseases or behavioral health conditions that require more frequent interactions.”

As shared by Rick Cotton, Founder and co-CEO of iHub Global, “Through the power of this partnership with BioDatAi, iHub’s affiliate network and their families will now have easy access to quality and affordable care, anytime that is convenient (24/7/365) simply by engaging our iHub Telehealth portal. Our members now have the ability to connect directly to licensed, board-certified physicians or therapists through a real-time telehealth video conference or telephone conversation to address their urgent care needs. Additionally, all medically related questions or concerns a member may have can be shared through the portal, with a private and personal response being provided directly from a certified physician. This innovative service has not been available to most people until now.”

BioDatAi is focused on delivering new innovative healthcare services and solutions that address the ever-changing needs of the global healthcare marketplace. Along with utilizing BioDatAi’s services themselves through this partnership, iHub has also obtained the exclusive rights to market and sell these telehealth services directly within the affiliate marketing, network marketing, and MLM marketspace.

“Today, sensitivity and concern related to one’s personal and family health are paramount,” added Dan Stammen, co-CEO of iHub, “however, getting easy access to healthcare providers is often difficult and expensive. Here at iHub, we want to help address this need by enhancing our current offerings to include the iHub Telehealth as a service to our market. At iHub, we truly want to help not only our own membership, but those community members in need, have access to the quality care they deserve, whenever and wherever they need it, without the burden of unknown costs and fees that often keep people from seeking the care they need.”

“We are excited to be partnering with iHub Global to collectively bring our telemedicine and telehealth services to market,” continues Mr. Cook. “The uniting of ETT and iHub Global, one of the largest and most progressive affiliate marketing companies, marks the beginning of a powerful partnership and collective commitment to bring new technology-enabled solutions to global markets.”

###

About BioDatAi

BioDatAi, established in 2019, is focused on delivering new innovative healthcare services and solutions that address the ever-changing needs of the global healthcare marketplace. Utilizing its state-of-the-art healthcare data platform, BioDatAi applies the strength of advanced data technologies like AI, machine learning, and NLP, to introduce a new breed of healthcare innovations that span providers to patients.

About iHub Global

iHub Global, established in early 2021, has quickly grown into a community of approximately one million global affiliate members, initially established to provide membership the ability to earn passive income through the installation of a Helium Hotspot Miner in their home that would mine Helium (HNT) cryptocurrency and compensate participants based on throughput, while also providing a hotspot that connects a variety of IoT devices across a distributed network. Beyond crypto-mining, iHub is committed to work with leading technology companies to bring develop and introduce new technology-enabled services and solutions across major markets.

Share article on social media or email: